Literature DB >> 8106588

Determination of free N-acetylneuraminic acid in human body fluids by high-performance liquid chromatography with fluorimetric detection.

K Hayakawa1, C De Felice, T Watanabe, T Tanaka, K Iinuma, K Nihei, S Higuchi, T Ezoe, I Hibi, K Kurosawa.   

Abstract

Determinations of both the free and bound form of N-acetyl-neuraminic acid (NANA) in several human body fluids, such as serum, cerebrospinal fluid (CSF), saliva, urine, amniotic fluid, and milk were carried out by HPLC with fluorimetric detection. The method utilized 1,2-diamino-4,5-methylenedioxybenzene dihydrochloride (DMB) as a fluorimetric derivatizing reagent. Free-form NANA was obtained from the body fluids after ultrafiltration with Microcon 10 (YM-10 cellulose membrane, filtration limit M(r) = 10,000, Amicon). The DMB derivative of NANA was separated isocratically by a Nucleosil 5C18 column with a mixture of 0.1 M sodium phosphate buffer (pH 2.0)-methanol (75:25, v/v). A gradient elution system was used for urine analysis. Analysis times were 10-30 min. Recoveries of free NANA by ultrafiltration were satisfactory: 95.66 +/- 1.80% for serum and 97.27 +/- 1.55% for CSF, respectively. The high sensitivity and specificity render this method applicable to all the body fluids tested. Although a physiological role for free NANA has not yet been elucidated, the method presented promises to contribute to the basic understanding of the NANA metabolism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8106588     DOI: 10.1016/0378-4347(93)80047-8

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder.

Authors:  L J M Spaapen; J A Bakker; S B van der Meer; H J Sijstermans; R A Steet; R A Wevers; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA).

Authors:  F Mochel; F Sedel; A Vanderver; U F H Engelke; J Barritault; B Z Yang; B Kulkarni; D R Adams; F Clot; J H Ding; C R Kaneski; F W Verheijen; B W Smits; F Seguin; A Brice; M T Vanier; M Huizing; R Schiffmann; A Durr; R A Wevers
Journal:  Brain       Date:  2009-01-19       Impact factor: 13.501

3.  Purification and characterization of a soluble recombinant human ST6Gal I functionally expressed in Escherichia coli.

Authors:  Kazuya I P J Hidari; Nobuhiro Horie; Takeomi Murata; Daisei Miyamoto; Takashi Suzuki; Taiichi Usui; Yasuo Suzuki
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 3.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.